Search is Powered by Google
Pain / Anesthetics News

The Process Of Pain Alleviation By Stress

Main Category: Pain / Anesthetics
Also Included In: Neurology / Neuroscience;  Biology / Biochemistry
Article Date: 06 Dec 2007 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

One way to alleviate the pain of banging your shin while on a hike is to encounter a grizzly bear - a well-known phenomenon called stress-induced analgesia. Now, researchers have elucidated a key mechanism by which the stress hormone noradrenaline - which floods the bloodstream during grizzly encounters and other stressful events - affects the brain's pain-processing pathway to produce such analgesia.

Pankaj Sah and colleagues published their findings in the December 6, 2007, issue of the journal Neuron, published by Cell Press.

In an accompanying perspective article on the research, Harvard Medical School researchers Keith Tully, Yan Li, and Vadim Bolshakov wrote that "The impressive new study… provides important mechanistic clues helping to explain this phenomenon."

In their experiments, Sah and colleagues studied a region of the amygdala, the brain's emotion-processing region known to mediate the emotional and stress-related aspects of pain. Researchers had long known that these amygdala-based processes were controlled by neurons that originated in the brainstem and that were regulated by noradrenaline.

Sah and colleagues sought in their studies to understand the mechanism by which noradrenaline influences neuronal transmission of pain inputs from the brainstem region known as the pontine parabrachial (PB).

In their experiments with rats, the researchers analyzed the effects of noradrenaline on electrical stimulation of the pathway between the PB and amygdala. They found that noradrenaline acted as a powerful suppressor of that stimulation. The researchers' studies also revealed that noradrenaline suppression acted on the "transmission" side of the connections between neurons, called synapses. Their analyses revealed how noradrenaline causes such suppression: by activating specific receptors, called adrenocreceptors, on the PB neurons.

The researchers' studies showed that noradrenaline's action appears to reduce the number of sites that launch the chemical signals called neurotransmitters by which one neuron triggers a nerve impulse in another, reported the researchers.

They concluded that "Our results show that an important mediator of stress-induced analgesia could be the potent modulation by noradrenaline of [pain] PB inputs in the central amygdala."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The researchers include Andrew J. Delaney, James W. Crane, and Pankaj Sah, of the Queensland Brain Institute, The University of Queensland, Australia.

Source: Cathleen Genova
Cell Press




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves Fibromyalgia Drug - Savella(TM) (milnacipran HCl), A Selective Serotonin And Norepinephrine Dual Reuptake Inhibitor
16 Jan 2009
Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella(TM) (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S...


Treating Chronic Pain image Treating Chronic Pain

Chronic pain is pain that continues past the normal healing time for an injury. Learn about the causes and current treatment options, from NSAIDs to opioids, for chronic pain...

What Is Chronic Pain? image What Is Chronic Pain?

Chronic pain can affect a person 24 hours a day. What causes chronic pain? And how can you get some relief...

View more videos...